427 related articles for article (PubMed ID: 19447197)
1. Risk of complications after abdominal paracentesis in cirrhotic patients: a prospective study.
De Gottardi A; Thévenot T; Spahr L; Morard I; Bresson-Hadni S; Torres F; Giostra E; Hadengue A
Clin Gastroenterol Hepatol; 2009 Aug; 7(8):906-9. PubMed ID: 19447197
[TBL] [Abstract][Full Text] [Related]
2. Unsuspected infection is infrequent in asymptomatic outpatients with refractory ascites undergoing therapeutic paracentesis.
Jeffries MA; Stern MA; Gunaratnam NT; Fontana RJ
Am J Gastroenterol; 1999 Oct; 94(10):2972-6. PubMed ID: 10520854
[TBL] [Abstract][Full Text] [Related]
3. Complications of thoracentesis in cirrhotic patients with pleural effusion.
Castellote J; Xiol X; Cortés-Beut R; Tremosa G; Rodríguez E; Vázquez S
Rev Esp Enferm Dig; 2001 Sep; 93(9):566-75. PubMed ID: 11767433
[TBL] [Abstract][Full Text] [Related]
4. Clinical and neurohumoral response to posture, physical exercise, and ascites treatment in Child-Pugh C liver cirrhosis: randomized prospective trial.
Degoricija V; Zjacic-Rotkvic V; Marout J; Sefer S; Troskot B
Croat Med J; 2003 Apr; 44(2):178-86. PubMed ID: 12698509
[TBL] [Abstract][Full Text] [Related]
5. Severe haemorrhage following abdominal paracentesis for ascites in patients with liver disease.
Pache I; Bilodeau M
Aliment Pharmacol Ther; 2005 Mar; 21(5):525-9. PubMed ID: 15740535
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous bacterial peritonitis and bacterascites prevalence in asymptomatic cirrhotic outpatients undergoing large-volume paracentesis.
Castellote J; Girbau A; Maisterra S; Charhi N; Ballester R; Xiol X
J Gastroenterol Hepatol; 2008 Feb; 23(2):256-9. PubMed ID: 17683477
[TBL] [Abstract][Full Text] [Related]
7. Mannitolum infusion on cirrhotic patients with tense ascites treated by paracentesis.
Zhao J; Yuan C; Wang D; Li X
Chin Med J (Engl); 2000 Jan; 113(1):27-30. PubMed ID: 11775204
[TBL] [Abstract][Full Text] [Related]
8. Long-term clinical outcome of large volume paracentesis with intravenous albumin in patients with spontaneous bacterial peritonitis: a randomized prospective study.
Choi CH; Ahn SH; Kim DY; Lee SK; Park JY; Chon CY; Moon YM; Han KH
J Gastroenterol Hepatol; 2005 Aug; 20(8):1215-22. PubMed ID: 16048569
[TBL] [Abstract][Full Text] [Related]
9. Total paracentesis in cirrhotic patients with tense ascites and dilutional hyponatremia.
Vila MC; Coll S; Solà R; Andreu M; Gana J; Marquez J
Am J Gastroenterol; 1999 Aug; 94(8):2219-23. PubMed ID: 10445553
[TBL] [Abstract][Full Text] [Related]
10. Effects of a selective vasopressin V2 receptor antagonist, satavaptan, on ascites recurrence after paracentesis in patients with cirrhosis.
Wong F; Gines P; Watson H; Horsmans Y; Angeli P; Gow P; Minini P; Bernardi M
J Hepatol; 2010 Aug; 53(2):283-90. PubMed ID: 20541828
[TBL] [Abstract][Full Text] [Related]
11. Performance standards for therapeutic abdominal paracentesis.
Grabau CM; Crago SF; Hoff LK; Simon JA; Melton CA; Ott BJ; Kamath PS
Hepatology; 2004 Aug; 40(2):484-8. PubMed ID: 15368454
[TBL] [Abstract][Full Text] [Related]
12. Should bleeding tendency deter abdominal paracentesis?
Lin CH; Shih FY; Ma MH; Chiang WC; Yang CW; Ko PC
Dig Liver Dis; 2005 Dec; 37(12):946-51. PubMed ID: 16185942
[TBL] [Abstract][Full Text] [Related]
13. Large-volume paracentesis versus dialytic ultrafiltration in the treatment of cirrhotic ascites.
Lai KN; Li P; Law E; Swaminathan R; Nicholls MG
Q J Med; 1991 Jan; 78(285):33-41. PubMed ID: 1670062
[TBL] [Abstract][Full Text] [Related]
14. Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites.
Sola-Vera J; Miñana J; Ricart E; Planella M; González B; Torras X; Rodríguez J; Such J; Pascual S; Soriano G; Pérez-Mateo M; Guarner C
Hepatology; 2003 May; 37(5):1147-53. PubMed ID: 12717396
[TBL] [Abstract][Full Text] [Related]
15. Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.
Appenrodt B; Wolf A; Grünhage F; Trebicka J; Schepke M; Rabe C; Lammert F; Sauerbruch T; Heller J
Liver Int; 2008 Aug; 28(7):1019-25. PubMed ID: 18410283
[TBL] [Abstract][Full Text] [Related]
16. Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid: a randomised controlled pilot trail.
Moreau R; Valla DC; Durand-Zaleski I; Bronowicki JP; Durand F; Chaput JC; Dadamessi I; Silvain C; Bonny C; Oberti F; Gournay J; Lebrec D; Grouin JM; Guémas E; Golly D; Padrazzi B; Tellier Z
Liver Int; 2006 Feb; 26(1):46-54. PubMed ID: 16420509
[TBL] [Abstract][Full Text] [Related]
17. Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: standard vs half albumin doses. A prospective, randomized, unblinded pilot study.
Alessandria C; Elia C; Mezzabotta L; Risso A; Andrealli A; Spandre M; Morgando A; Marzano A; Rizzetto M
Dig Liver Dis; 2011 Nov; 43(11):881-6. PubMed ID: 21741331
[TBL] [Abstract][Full Text] [Related]
18. Paracentesis: a re-evaluated procedure in the management of cirrhotic patients with ascites.
Salerno F; Badalamenti S; Incerti P; Moser P; Capozza L; Lorenzano E; Restelli B
Ital J Gastroenterol; 1990 Feb; 22(1):44-9. PubMed ID: 2131928
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors of cirrhotic patients in extra-hepatic surgery.
Franzetta M; Raimondo D; Giammanco M; Di Trapani B; Passariello P; Sammartano A; Di Gesù G
Minerva Chir; 2003 Aug; 58(4):541-4. PubMed ID: 14603166
[TBL] [Abstract][Full Text] [Related]
20. Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.
Singh V; Kumar R; Nain CK; Singh B; Sharma AK
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):303-7. PubMed ID: 16460491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
